The RheOx ® system for the treatment of the symptoms of chronic bronchitis consists of a proprietary electrosurgical generator and a single-use catheter. The minimally-invasive bronchoscopic therapy delivers short bursts of Pulsed Electric Field (PEF) energy to induce non-thermal ablation of the abnormal mucus-producing cells in the airways ...

Bronchial rheoplasty is a procedure that uses nonthermal pulsed electrical fields with the intention of ablating the abnormal mucus-producing cells of the airway epithelium, thereby allowing normal, healthy epithelial regeneration to occur.

What is Bronchial Rheoplasty? This is a device therapy being studied for patients with COPD and chronic sputum production. In the study, a small tube called a bronchoscope is placed in the lungs under anesthesia. Through that, a catheter is introduced, and non-heat pulsed electrical stimulation is applied to mucus secreting cells in the lungs.

Right now, doctors at our research center are conducting a new research study of Bronchial Rheoplasty using RheOx™, an investigational device designed to reduce cough and mucus production through a minimally-invasive procedure.

Sep 4, 2020 · RheOx is a bronchoscopic system designed to reduce mucus-producing cells in patients with chronic bronchitis. The technology includes an electrosurgical generator and a single-use catheter that together deliver non-thermal energy to the airways to reduce the number of abnormal mucus-producing cells in the lungs, making way for new normal cells ...

Sep 29, 2022 · Observational study — observes people and measures outcomes without affecting results. Interventional study (clinical trial) — studies new tests, treatments, drugs, surgical …

Jun 19, 2023 · The minimally invasive RheOx System delivers non-thermal pulsed electric field (PEF) energy to destroy abnormal, mucus-producing cells on the surface of the lung airways.

Aug 17, 2020 · Antibiotics and steroids can give short-term relief, but there's no cure for chronic bronchitis, and long-term treatments have been limited. Temple is one of the U.S. sites testing a new option...

Feb 23, 2021 · The upcoming trial, called RheSolve (NCT04677465), will evaluate the safety and effectiveness of the RheOx System in up to 270 adults, ages 35 and older, with COPD and moderate to severe chronic bronchitis.

Sep 17, 2019 · RheOx is a bronchoscopic system designed to reduce mucus-producing cells in patients with Chronic Bronchitis. The revolutionary technology includes an electrosurgical generator and a single-use catheter that together deliver non-thermal energy to the airways to reduce the number of abnormal mucus-producing cells in the lungs, making way for new ...